T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression-Reference-Cited by-同舟云学术

T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression

Published:2018-07 Issue:7 Volume:29 Page:1575-1581
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Andersen R.,Borch T.H.,Draghi A.,Gokuldass A.,Rana M.A.H.,Pedersen M.,Nielsen M.,Kongsted P.,Kjeldsen J.W.,Westergaard M.C.W.,Radic H.D.,Chamberlain C.A.,Hölmich L.R.,Hendel H.W.,Larsen M.S.,Met Ö,Svane I.M.,Donia M.^ORCID

Funder

The Danish Cancer Society

Aase and Einar Danielsen Foundation

The Beckett Foundation

Herlev and Gentofte Hospital Research Council

The Danish Council for Independent Research

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdy139/25009114/mdy139.pdf

Reference26 articles.

1. The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition;Hegde;Clin Cancer Res,2016

2. Adoptive cell therapy for metastatic melanoma;Merhavi-Shoham;Cancer J,2017

3. Resistance to checkpoint blockade therapy through inactivation of antigen presentation;Sade-Feldman;Nat Commun,2017

4. The effect of alpha and gamma interferon on cell growth and histocompatibility antigen expression by human renal carcinoma cells in vitro;Angus;Eur J Cancer,1993

5. Interferon alpha increases the frequency of interferon gamma-producing human cd4+ T cells;Brinkmann;J Exp Med,1993

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontiers and challenges of immune cell therapy research in solid tumors;Chinese Science Bulletin;2024-08-20

2. Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways;Cancer Immunology Research;2024-06-17

3. Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma;Journal for ImmunoTherapy of Cancer;2024-05

4. Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes;Cancer Immunology Research;2024-04-17

5. Molecular patterns of resistance to immune checkpoint blockade in melanoma;Nature Communications;2024-04-09